Group One Trading
ALDR

Group One Trading’s Alder Biopharmaceuticals ALDR Stock Holding History

Group One Trading’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-47,000
Closed -$886K – 5975
2019
Q3 		$886K Buy
47,000
+45,500
+3,033% +$520K 0.01% 1838
2019
Q2 		$18K Sell
1,500
-500
-25% -$6.05K ﹤0.01% 4222
2019
Q1 		$27K Sell
2,000
-1,100
-35% -$14.3K ﹤0.01% 3904
2018
Q4 		$32K Sell
3,100
-13,800
-82% -$177K ﹤0.01% 3786
2018
Q3 		$281K Sell
16,900
-9,200
-35% -$166K ﹤0.01% 2760
2018
Q2 		$412K Buy
26,100
+18,500
+243% +$281K ﹤0.01% 2454
2018
Q1 		$97K Sell
7,600
-46,300
-86% -$670K ﹤0.01% 3273
2017
Q4 		$617K Buy
53,900
+5,000
+10% +$55.8K ﹤0.01% 2090
2017
Q3 		$599K Buy
48,900
+42,800
+702% +$446K 0.01% 1936
2017
Q2 		$70K Buy
+6,100
New +$113K ﹤0.01% 3329
2017
Q1 		– Sell
-3,500
Closed -$73K – 5221
2016
Q4 		$73K Buy
+3,500
New +$91K ﹤0.01% 3026

Group One Trading's ALDR Position: Q4 2019 in Review

Group One Trading sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 25,332 shares — an estimated $478K sold.

Group One Trading first reported a position in ALDR in Q2 2015 and held it in 16 quarters. The position peaked at $824K in Q3 2015. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

  • Group One Trading reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Group One Trading sold 25,332 Alder Biopharmaceuticals shares in Q4 2019, an estimated $478K.
  • Group One Trading first reported a position in Alder Biopharmaceuticals in Q2 2015 and held it in 16 quarters.
  • Group One Trading's Alder Biopharmaceuticals position peaked at $824K in Q3 2015.
  • 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Group One Trading's 13F filing for Q4 2019, filed 10 Feb 2020.